E-viri
PDF
Recenzirano
Odprti dostop
-
Kirpalani, Haresh; Bell, Edward F; Hintz, Susan R; Tan, Sylvia; Schmidt, Barbara; Chaudhary, Aasma S; Johnson, Karen J; Crawford, Margaret M; Newman, Jamie E; Vohr, Betty R; Carlo, Waldemar A; D’Angio, Carl T; Kennedy, Kathleen A; Ohls, Robin K; Poindexter, Brenda B; Schibler, Kurt; Whyte, Robin K; Widness, John A; Zupancic, John A.F; Wyckoff, Myra H; Truog, William E; Walsh, Michele C; Chock, Valerie Y; Laptook, Abbot R; Sokol, Gregory M; Yoder, Bradley A; Patel, Ravi M; Cotten, C. Michael; Carmen, Melissa F; Devaskar, Uday; Chawla, Sanjay; Seabrook, Ruth; Higgins, Rosemary D; Das, Abhik
The New England journal of medicine, 12/2020, Letnik: 383, Številka: 27Journal Article
In this open, randomized, multicenter trial involving extremely-low-birth-weight preterm infants, the use of a higher hemoglobin threshold for red-cell transfusion did not improve survival without neurodevelopmental impairment at 22 to 26 months of age, corrected for prematurity.
